Japan Single Cell Analysis Market Size & Outlook, 2026-2033
- Biotechnology
- Bioprocessing
- Single Cell Analysis Market Outlook
- Bioprocessing
Global Market
Related Markets
Ask Prism AI anything about the single cell analysis market
Get a cited answer from GVR research in seconds: segment shares, growth drivers, regulation and forecast assumptions.
Japan single cell analysis market highlights
- The Japan single cell analysis market generated a revenue of USD 154.4 million in 2025 and is expected to reach USD 870.5 million by 2033.
- The Japan market is expected to grow at a CAGR of 25.2% from 2026 to 2033.
- In terms of segment, consumables was the largest revenue generating product in 2025.
- Consumables is the most lucrative product segment registering the fastest growth during the forecast period.
Single cell analysis market data book summary
| Market revenue in 2025 | USD 154.4 million |
| Market revenue in 2033 | USD 870.5 million |
| Growth rate | 25.2% (CAGR from 2026 to 2033) |
| Largest segment | Consumables |
| Fastest growing segment | Consumables |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Consumables |
| Key market players worldwide | Thermo Fisher Scientific Inc, Qiagen NV, Bio-Rad Laboratories Inc, Illumina Inc, Merck KGaA, Becton Dickinson & Co, Standard BioTools Inc, 10x Genomics Inc Ordinary Shares - Class A, BGI Group, Novogene |
Other key industry trends
- In terms of revenue, Japan accounted for 2.8% of the global single cell analysis market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China single cell analysis market is projected to lead the regional market in terms of revenue in 2033.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 870.5 million by 2033.
Japan is one of the leaders in Asia Pacific due to its rapid technological advancements and strategic initiatives to maximize return on investments. In addition, several foreign companies are entering the single-cell analysis market. In May 2021, Chugai launched a cryo-electron microscopy system in Japan to accelerate drug discovery.
The company is investing significant funds to obtain the technology used in the Western markets by acquiring smaller stem cell companies. In August 2019, Atonarp, a Japanese company, announced plans to raise USD 33 million in equity funds to support its commercialization of mass and optical spectrometry for diagnostic & industrial applications.
As of March 2023, the Japanese government strategically allocated a USD 75 billion endowment fund to specific universities. This investment empowers the universities to conduct high-quality research and enhance global competitiveness.
No credit card required*
Publish Date: Jul 01, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Single Cell Analysis Market Scope
Single Cell Analysis Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Becton Dickinson & Co | View profile | 73,000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | www.bd.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Standard BioTools Inc | View profile | 539 | 2 Tower Place, Suite 2000, South San Francisco, CA, United States, 94080 | www.standardbio.com |
| Novogene | View profile | 501-1000 | Beijing, Beijing, China, Asia | en.novogene.com/ |
| 10x Genomics Inc Ordinary Shares - Class A | View profile | 1,259 | 6230 Stoneridge Mall Road, Pleasanton, CA, United States, 94588 | www.10xgenomics.com |
| BGI Group | View profile | 5001-10000 | Shenzhen, Guangdong, China, Asia | www.genomics.cn/ |
Japan Single Cell Analysis Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Single Cell Analysis Market Outlook will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 64.64% in 2025.
Horizon Databook has segmented the Japan single cell analysis market based on instruments, consumables covering the revenue growth of each sub-segment from 2021 to 2033.
Japan is one of the leaders in Asia Pacific due to its rapid technological advancements and strategic initiatives to maximize return on investments. In addition, several foreign companies are entering the single-cell analysis market. In May 2021, Chugai launched a cryo-electron microscopy system in Japan to accelerate drug discovery.
The company is investing significant funds to obtain the technology used in the Western markets by acquiring smaller stem cell companies. In August 2019, Atonarp, a Japanese company, announced plans to raise USD 33 million in equity funds to support its commercialization of mass and optical spectrometry for diagnostic & industrial applications.
As of March 2023, the Japanese government strategically allocated a USD 75 billion endowment fund to specific universities. This investment empowers the universities to conduct high-quality research and enhance global competitiveness.
- Japan Single Cell Analysis Market Product Outlook (Revenue, USD Million , 2021-2033)
- Consumables
- Instruments
- Japan Single Cell Analysis Market Application Outlook (Revenue, USD Million , 2021-2033)
- Cancer
- Immunology
- Neurology
- Stem Cell
- Non invasive prenatal diagnosis
- In vitro Fertilisation
- Other Application
- Japan Single Cell Analysis Market Workflow Outlook (Revenue, USD Million , 2021-2033)
- Single Cell Isolation & Library Preparation
- Downstream Analysis
- Data Analysis
- Japan Single Cell Analysis Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Academic & Research Laboratories
- Biotechnology and Pharmaceutical Companies
- Hospitals and Diagnostic Laboratories
- Other End Use
Reasons to subscribe to Single Cell Analysis Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Single Cell Analysis Market Outlook databook
- Our clientele includes a mix of Single Cell Analysis Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan Single Cell Analysis Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Japan Single Cell Analysis Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Japan Single Cell Analysis Market, 2021-2033 (US$M)
Japan Product - Single Cell Analysis Market Statistics, 2025 - 2033 (US$M)
